Phase III, double-blind, placebo-controlled, crossover study evaluating a 5HT3 antagonist plus dexamethasone with or without aprepitant in patients with germ cell tumor receiving 5-day cisplatin combination chemotherapy: A Hoosier Oncology Group (HOG) study.
M. J. Brames
No relevant relationships to disclose
J. Picus
No relevant relationships to disclose
M. Yu
No relevant relationships to disclose
E. L. Johnston
No relevant relationships to disclose
B. Bottema
No relevant relationships to disclose
C. E. Williams
No relevant relationships to disclose
L. H. Einhorn
No relevant relationships to disclose